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INTRODUCTION
FA is a rare autosomal instability syndrome characterized by
progressive bone marrow failure, various congenital malformations,
predisposition to malignancy and cellular hypersensitivity to cross
linking agents, because of inability to correct DNA damage. (Figure
1.A)
On the molecular level there is considerable heterogeneity in FA with
13 genes (A, B, C, D1, D2, E, F, G, I, J, L, M, N), currently
recognised. The FA core complex containing the FA proteins
(A/B/C/E/F/G/L/M) is required for the activation of the FANCD2
protein to a monoubiquitinated isoform (FANCD2-Ub), which interacts
with DNA repair proteins leading to repair of the cross-link. In FA
patients the FA pathway does not work properly. (Figure 1.B)
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Figure 1: A. Chromosomal changes that can occur in response to DNA-
Interstand-Crosslink Damage. (adopted from Niedernhofer et al., Cell 123 :
1191-1198, 2005 ). B. An overview of the pathway. ( adopted from Patel et
al. , DNA Repair, 6 : 885-890, 2007)
PATIENTS
We report on 97 children ,aged 2 months-14 years , who were
referred to the Department of Medical Genetics from 2007-2010
for genetic investigation after the clinical suspicion (myelodysplasia
and/or congenital anomalies) of FA. Peripheral blood samples were
analysed originally with cytogenetic techniques. If the results were
positive molecular analysis followed. Matched for age and sex
controls were used. Carrier detection was performed in family
members of FA patients.
METHODS
Peripheral blood samples were analysed with conventional cytogenetic
techniques. For clastogen-induced chromosome damage MMC and
DEB were added in two different sets of cultures. The final
concentration for MMC was 3 μg/5ml and 5 μg/5ml and cells were
cultured for 72 hours. DEB was added to the cultures 24 hours after
initiation at a final concentration of 0,6 μg/5ml, thus exposing the
cells to the chemical for 48 hours. A minimum of 150 metaphases per
case were analysed.
As FA positive was concidered the case in which the percentage of
breaks was 7-10 times higher as compared to control.
Molecular investigation was performed using the Multiplex Ligation-
dependent Probe Amplification (MLPA) technique to detect deletions
of the FANCA gene which account for more than 65% of Fanconi
Anaemia cases. PO31/32 is the commercially available kit that was
used.
RESULTS
Cytogenetic testing
Induced breaks and radial formations were detected in 7/97
patients with both clustogens (Figure 2). 3/7 FA patients
presented with congenital anomalies and 4/7 had aplastic
anαemia.
Molecular testing
DNA from the 7 patients were subsequently tested for
deletions of the FANCA gene. Molecular analysis showed that
5/7 belonged to the FA A subtype. Two were dizygotic twins,
compound heterozygous for the same deletions (Figure 3).
16 family members were tested for carrier detection and 6
were identified as heterozygous for deletions of the FANCA
gene.
Figure 2 : Metaphase spread from a FA patient, after exposure to
MMC, exhibiting multiple chromosomal breaks and radial formations.
FANCA GENE FATHER MOTHER 1st TWIN
exon 01 0,52 0,95 0,52
exon 02 0,56 0,94 0,54
exon 03 0,53 1,1 0,55
exon 04 0,55 1 0,48
exon 05 0,55 1,18 0,57
exon 06 0,99 1,08 0,99
exon 07 0,98 0,4 0,42
exon 08 1,1 0,36 0,6
exon 09 1,12 0,51 0,52
exon 10 0,98 0,5 0,53
exon 11 0,97 0,6 0,52
exon 12 0,91 0,48 0,48
exon 13 1,1 0,42 0,54
exon 14 1 0,49 0,54
exon 15 0,97 0,63 0,48
exon 16 0,95 0,54 0,47
exon 17 1,11 0,58 0,48
exon 18 1,12 0,91 1
exon 19 1 0,96 0,98
exon 20 1.1 0,99 0,99
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Figure 3 : Dizygotic twins, compound heterozygotes for FANCA gene
deletions. Deletion of exons 1-5 is of paternal origin and del of exons 7-17
is of maternal.
CONCLUSION
7% of patients, referred for FA investigation, were FA
positive and of those 71 % belonged to the FA A subtype.
Accurate and timely diagnosis is important in order to implement
appropriate therapy, bone marrow transplantation and genetic
counselling.
